Cardarelli PM, Quinn M, Buckman D, Fang Y, Colcher D, King DJ, Bebbington C, Yarranton G. Binding to CD20 by anti-B1 antibody or F(ab')(2) is sufficient for induction of apoptosis in B-cell lines. Cancer Immunol Immunother; 2002, 51(1): 15-24.
Chen X, Shen B, Xia L, Khaletzkiy A, Chu D, Wong JY, Li JJ. Activation of nuclear factor kappaB in radioresistance of TP53-inactive human keratinocytes. Cancer Res; 2002, 62(4): 1213-21.
DeNardo SJ, Williams LE, Leigh BR, Wahl RL. Choosing an optimal radioimmunotherapy dose for clinical response. Cancer; 2002, 94(4 Suppl): 1275-86.
Dussault I, Lin M, Hollister K, Fan M, Termini J, Sherman MA, Forman BM. A structural model of the constitutive androstane receptor defines novel interactions that mediate ligand-independent activity. Mol Cell Biol; 2002, 22(15): 5270-80.
Epel M, Ellenhorn JD, Diamond DJ, Reiter Y. A functional recombinant single-chain T cell receptor fragment capable of selectively targeting antigen-presenting cells. Cancer Immunol Immunother; 2002, 51(10): 565-73.
Kurizaki T, Okazaki S, Sanderson SD, Colcher D, Enke CA, Tempero MA, Baranowska KJ. Potentiation of radioimmunotherapy with response-selective peptide agonist of human C5a. J Nucl Med; 2002, 43(7): 957-67.
Li L, Olafsen T, Anderson AL, Wu A, Raubitschek AA, Shively JE. Reduction of kidney uptake in radiometal labeled peptide linkers conjugated to recombinant antibody fragments. Site-specific conjugation of DOTA-peptides to a Cys-diabody. Bioconjug Chem; 2002, 13(5): 985-95.
Li L, Tsai SW, Anderson AL, Keire DA, Raubitschek AA, Shively JE. Vinyl sulfone bifunctional derivatives of DOTA allow sulfhydryl- or amino-directed coupling to antibodies. Conjugates retain immunoreactivity and have similar biodistributions. Bioconjug Chem; 2002, 13(1): 110-5.
Pezner RD, Chu DZ, Ellenhorn JD. Intraoperative radiation therapy for patients with recurrent rectal and sigmoid colon cancer in previously irradiated fields. Radiother Oncol; 2002, 64(1): 47-52.
Reeve JR, McVey DC, Bunnett NW, Solomon TE, Keire DA, Ho FJ, Davis MT, Lee TD, Shively JE, Vigna SR. Differences in receptor binding and stability to enzymatic digestion between CCK-8 and CCK-58. Pancreas; 2002, 25(3): e50-5.
Sun JY, Chatterjee S, Wong KK. Immunogenic issues concerning recombinant adeno-associated virus vectors for gene therapy. Curr Gene Ther; 2002, 2(4): 485-500.
Sun JY, Krouse RS, Forman S, Senitzer D, Sniecinski I, Chatterjee S, Wong KK. Immunogenicity of a P210BCR-ABL Fusion Domain Candidate DNA Vaccine Targeted to Dendritic Cells by an rAAV Vector In Vitro. Cancer Res; 2002; 62: 3175-3183.
Williams LE, Liu A, Yamauchi DM, Lopatin G, Raubitschek AA, Wong JY. The two types of correction of absorbed dose estimates for internal emitters. Cancer; 2002, 94(4 Suppl): 1231-4.
Peng Y, Liu CP. The cross-reactivity of I-A(g7) and I-A(d) tetramers. Chinese Medical Journal; 2002, 115(10): 1579-1581.
Peng Y, Liu CP. Characterization of proteolipid protein-peptide-specific CD4+ T cell of experimental allergic encephalomyelitis in Biozzi AB/H mice. Chinese Medical Journal; 2002, 115(4): 521-524.
